poractant alfa

poractant alfa

 [por-ak´tant al´fah]
an extract of porcine lung surfactant administered by instillation via the endotracheal tube in treatment of respiratory distress syndrome of the newborn.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
References in periodicals archive ?
Sales of Curosurf[R] (poractant alfa), a pulmonary surfactant, exceeded [euro]200m, growing by 14.4% over 2014 and confirming its global importance as a potentially life-saving drug.
Compliations among premature neonates treated with beractant and poractant alfa. Indian J Pediatr 2010; 77: 751-4.
A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
27 January 2012 - Cornerstone Therapeutics (NASDAQ:CRTX), a specialty pharmaceutical group focused on products for respiratory conditions, said that a new analysis revealed significant benefits in mortality rate and the need for redosing in the treatment of neonatal respiratory distress syndrome (RDS) with the company's CUROSURF (poractant alfa) Intratracheal Suspension.
The biological surfactant preparation Curosurf (poractant alfa) was derived from minced porcine lung extracts, and its indications followed similar risk profiles as noted in the biologicals above.
* Poractant alfa (Curosurf) for respiratory distress syndrome.
A randomized, multicenter masked comparison trial of poractant alfa (Curosurf ) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Examples of natural surfactant include Beractant (Survanta), Poractant Alfa (Curosurf), and Clafactant (Infasurf)